2015 ESC Guidelines on the management of infective endocarditis: A big step forward for an old disease

Heart

Volumn 102, Issue 13, 2016, Pages 992-994

  Habib, Gilbert ^a,b   Lancellotti, Patrizio ^c,d   Iung, Bernard ^e  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Anthea Hospital   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; BACTERIAL CLEARANCE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; COMPUTER ASSISTED TOMOGRAPHY; EARLY INTERVENTION; ECHOCARDIOGRAPHY; HEALTH CARE; HEALTH CARE ACCESS; HEART SURGERY; HUMAN; INFECTION PREVENTION; MOUTH HYGIENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; CARDIAC IMAGING; CARDIOLOGY; DIAGNOSTIC IMAGING; ENDOCARDITIS; MORTALITY; PREDICTIVE VALUE; RISK FACTOR; STANDARDS; TREATMENT OUTCOME;

CARDIAC IMAGING TECHNIQUES; CARDIOLOGY; ENDOCARDITIS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84973333863     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308791     Document Type: Review

References (10)

1. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
2. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128.
3. Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015;65:2070-6.
4. Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet 2015;385:1219-28.
5. Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009;169:1290-8.
6. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438-88.
7. Bruun NE, Habib G, Thuny F, et al. Cardiac imaging in infectious endocarditis. Eur Heart J 2014;35:624-32.
8. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A scientific statement for healthcare professionals from the American Heart Association. Circulation 2015;132:1435-86.
9. Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012;366:2466-73.
10. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.